What are FUL's recent SEC filings?
Robert J. Martsching resigned as Vice President, Corporate Controller, and principal accounting officer of H.B. Fuller effective November 9, 2026, and will remain through January 2027 to assist with the pending acquisition integration. Sarah R. Nickless was appointed as his successor effective the same day.
View full filing details →H.B. Fuller Company entered into a Third Supplemental Indenture establishing a new series of 7.625% Notes due 2034 with an initial aggregate principal amount of $850 million.
View full filing details →H.B. Fuller's Board unanimously rejected Ancora's second unsolicited, non-binding proposal to acquire its Building Adhesive Solutions segment for $1.2-1.4 billion in cash, citing inadequate value and highly conditional terms. The company also announced it will conduct a market check for select less-integral market segments and product lines, with intent to use proceeds for deleveraging.
View full filing details →H.B. Fuller priced a private offering of $850 million in 7.625% senior unsecured notes due 2034, with proceeds intended to fund the acquisition of Advanced Medical Solutions Group plc, repay credit agreement borrowings, and redeem its 4.000% notes due 2027.
View full filing details →H.B. Fuller filed an 8-K containing unaudited pro forma financial information related to its acquisition of AMS, showing combined net revenue of approximately $3.87 billion and pro forma net income of $100.3 million for the twelve months ended August 29, 2026.
View full filing details →H.B. Fuller appointed R. Jeffrey Bailly to its Board of Directors, effective immediately, and Ruth Kimmelshue stepped down from the Board.
View full filing details →H.B. Fuller reported Q3 2026 results with net revenue up 5.2% to $938 million and adjusted EPS of $1.52, up 21% year-on-year. The company raised its fiscal 2026 adjusted EBITDA guidance to $655-$670 million and adjusted EPS guidance to $4.70-$4.85.
View full filing details →H.B. Fuller Company filed its quarterly report on Form 10-Q for the period ended September 24, 2026, with CEO Celeste B. Mastin certifying the accuracy of financial statements and effectiveness of disclosure controls.
View full filing details →Has FUL ever done a stock split?
No stock splits are recorded for FUL.
What is FUL's share float?
Get Real-Time FUL Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free